MedPath

Effectiveness of Combined intravenous and Periarticular Tranexamic acid compare to Intravenous Tranexemic acid alone for decreasing blood loss in Simultaneous Bilateral Total Knee Arthroplasty

Phase 3
Conditions
elderly osteoarthritis patients
Bilateral total knee arthroplasty , combined periarticular tranexamic acid and intravenous tranexamic, intravenous tranexamic
Registration Number
TCTR20221229004
Lead Sponsor
Charoenkrung Pracharak Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
60
Inclusion Criteria

Severe osteoarthritis stage 3-4 both legs

Exclusion Criteria

1. Ischemic heart disease on antiplatelet drug
2. contraceptive pill
3. Pulmonary embolism 4. MI 5. Stroke 6. TIA 7. Coagulation defect 8. Allergy of tranexamic acid 9. Anemia (Hb < 11g/dL) 10. BMI >30 11.Serum creatinine > 1.35 mg/10 ml

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath